| Authors | Prithviraj Bose, Srdan Verstovsek, Jorge E Cortes, Susan Tse, Yvonne Gasior, Nitin Jain, Elias J Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D DiNardo, Naveen Pemmaraju, Steven M Kornblau, Tapan M Kadia, Naval G Daver, Kiran Naqvi, Nicholas J Short, Lucia Masarova, John Villareal, Sherry A Pierce, Graciela Nogueras-Gonzalez, Xuelin Huang, Guillermo Garcia-Manero, Hagop M Kantarjian, Farhad Ravandi |
| Journal | Leukemia
(Leukemia)
Vol. 34
Issue 9
Pg. 2489-2492
(09 2020)
ISSN: 1476-5551 [Electronic] England |
| PMID | 32099037
(Publication Type: Clinical Trial, Phase I, Clinical Trial, Phase II, Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Nitriles
- Pyrazoles
- Pyrimidines
- Decitabine
- ruxolitinib
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Decitabine
(administration & dosage)
- Dose-Response Relationship, Drug
- Female
- Humans
- Leukemia, Myeloid, Acute
(drug therapy)
- Male
- Middle Aged
- Myeloproliferative Disorders
(pathology)
- Neoplasms, Second Primary
(drug therapy)
- Nitriles
- Pyrazoles
(administration & dosage)
- Pyrimidines
- Treatment Outcome
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
